H&T Presspart once again exhibited at CPHI Milan, which took place from 6–8 October 2026 at Fiera Milano, bringing together pharmaceutical industry professionals from across the globe. The event provided an excellent opportunity to showcase our extensive drug-delivery portfolio, strengthen existing customer relationships and explore new business opportunities. 

Showcasing our drug-delivery solutions 

A key focus of our stand this year was our expanding portfolio of parenteral solutions. At CPHI Milan, we introduced Vylo™ cartridge seals to the market, offering a solution for reliable cartridge sealing across pharmaceutical and healthcare applications. We also showcased Vytal®, our ready-to-use (RTU) snap-fit vial closure, designed to meet the evolving requirements of advanced therapeutics and modern aseptic filling processes. For the first time, we also presented Plas-Tech Engineering’s Equinox® range of pre-fillable syringes, developed as a glass-replacement solution for pharmaceutical and biological drug delivery. 

Alongside our parenteral portfolio, our stand featured H&T Presspart’s comprehensive range of inhalation components and devices, including MDI canisters, actuators, dose counters and our Sunriser® DPI technology. A particular focus within our inhalation offering was how we are supporting the transition towards lower-carbon metered-dose inhalers (MDIs). We highlighted our next-generation, PFAS-free surface treatment technologies, alongside our analytical services to support customers in evaluating and transitioning to lower-carbon propellants. 

Together, these solutions demonstrate H&T Presspart’s continued commitment to expanding our capabilities, advancing drug-delivery technologies and supporting customers as they respond to evolving industry requirements. 

Connecting with customers and industry partners 

Beyond the products on display, CPHI Milan provided a valuable opportunity for our team to engage in meaningful conversations with existing customers, prospective partners and industry colleagues. Discussions covered current projects, emerging requirements and new opportunities for collaboration, reinforcing the importance of building strong, long-term partnerships. 

The event also allowed us to highlight the breadth of our device design and development services, demonstrating how H&T Presspart can support customers throughout the development journey — from initial concepts and prototyping through to industrialisation and manufacturing. 

Looking ahead 

CPHI Milan was a positive and productive event for H&T Presspart, helping us strengthen relationships, generate new business opportunities and gain further insight into the evolving needs of the pharmaceutical industry. 

We would like to thank everyone who visited our stand and took the time to meet with our team. We look forward to continuing these conversations and working together to advance the next generation of drug-delivery solutions. 

 
We look forward to seeing you next year in Frankfurt.